Recombinant Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Human monoclonal [H6] to SARS-CoV-2 spike glycoprotein - Chimeric
- Suitable for: ELISA, WB, Functional Studies
Related conjugates and formulations
Overview
-
Product name
Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric)
See all SARS-CoV-2 spike glycoprotein primary antibodies -
Description
Human monoclonal [H6] to SARS-CoV-2 spike glycoprotein - Chimeric -
Host species
Human -
Specificity
We have in-house data that suggests this product also reacts with SARS-CoV-1 spike protein in Western blot.
-
Tested applications
Suitable for: ELISA, WB, Functional Studiesmore details -
Species reactivity
Reacts with: SARS-CoV, SARS-CoV-2 -
Immunogen
Recombinant fragment corresponding to Human SARS-CoV-2 spike glycoprotein aa 16-685.
Database link: P0DTC2 -
Positive control
- WB: SARS-Cov1 spike protein transfected Expi cell lysate, SARS-Cov1 3xFlag spike protein transfected Expi cell lysate, SARS-Cov2 spike protein transfected Expi cell lysate and SARS-Cov2 3xFlag spike protein transfected Expi cell lysate.
-
General notes
Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) is a recombinant human/mouse chimeric monoclonal antibody consisting of Mouse scFv fused with human IgG1.
As the Fc region is human, an anti-Human secondary antibody should be used for detection. A suitable anti-Mouse secondary may also be used.
Applications overview
Tick: Tested and Guaranteed to work X: Will not work —: No data
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.40
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol (glycerin, glycerine), PBS -
Concentration information loading...
-
Purity
>90% by SDS-PAGE -
Purification notes
Screened the positive clones from mouse ScFv antibody libraries, then expressed in 293F cells. -
Clonality
Monoclonal -
Clone number
H6 -
Isotype
IgG1 -
Research areas
Associated products
-
Alternative Versions
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab272854 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA | (1) |
1/10000 - 1/50000.
|
WB |
Use a concentration of 1 µg/ml.
|
|
Functional Studies |
Use at an assay dependent concentration.
|
Notes |
---|
ELISA
1/10000 - 1/50000. |
WB
Use a concentration of 1 µg/ml. |
Functional Studies
Use at an assay dependent concentration. |
Images
-
All lanes : Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) at 1 µg/ml
Lane 1 : Mock transfected Expi cell lysate
Lane 2 : PDL-1 Flag transfected Expi cell lysate
Lane 3 : SARS-Cov1 spike protein transfected Expi cell lysate
Lane 4 : SARS-Cov1 3xFlag spike protein transfected Expi cell lysate
Lane 5 : SARS-Cov2 spike protein transfected Expi cell lysate
Lane 6 : SARS-Cov2 3xFlag spike protein transfected Expi cell lysate
Lane 7 : MERS Spike protein transfected Expi cell lysate
Lane 8 : MERS 3xFlag Spike protein transfected Expi cell lysate
Lysates/proteins at 10 µg per lane.
Performed under reducing conditions.
Observed band size: 200 kDa why is the actual band size different from the predicted?Lanes 1 - 8: Merged signal (red and green). Green - ab272854 observed at 200 kDa. Red - loading control.
ab272854 was shown to react with SARS-CoV-2 spike glycoprotein in western blot. Membranes were blocked in 3% milk before incubation with ab272854 overnight at 4°C at 1 ug/ml. Blots were incubated with Donkey anti-Mouse IgG H&L(IRDye® 800CW) preabsorbed (ab216774) antibody at 1 in 20000 dilution for 1 hour at room temperature before imaging.
Note: ab216774 is suitable for the recognition of the Mouse scFv fragment of ab272854.
-
Binding Activity of ab272854 with SARS-CoV-2 spike glycoprotein.
Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 spike glycoprotein at 2 μg/ml can bind ab272854. The EC50 of ab272854 is 36.79-48.87 ng/ml. -
Binding Activity of ab272854 with SARS-CoV-2-S1-RBD
Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD at 2 μg/ml can bind ab272854, the EC50 of SARS-CoV-2-S Antibody is 19.60-39.42 ng/ml. -
Functional Studies - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854)
Binding signal of Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) and SARS-CoV-2-S1-RBD was inhibited by ACE2 protein-HRP conjugated inhibitor with the IC50 23.32 nM.
-
Functional Studies - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854)
Binding signal of Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) and SARS-CoV-2-S1-RBD was inhibited by ACE2 protein-HRP conjugated inhibitor with the IC50 2.38 µg/mL.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab272854 has been referenced in 1 publication.
- Boix-Besora A et al. Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2. Vaccines (Basel) 10:N/A (2022). PubMed: 35214708